tradingkey.logo
tradingkey.logo
Search

Werewolf Therapeutics Inc

HOWL
Add to Watchlist
0.353USD
-0.147-29.44%
Close 07-31 16:00ETQuotes delayed by 15 min
17.16MMarket Cap
LossP/E TTM

HOWL Financials

See Werewolf Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Werewolf Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.28/-0.29
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
-1.32
18.78%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
120.01%0.08
31.00%-0.28
62.28%-0.17
6.32%-0.36
-0.87%-0.40
-3.68%-0.40
-39.76%-0.46
-64.19%-0.38
-176.44%-0.40
-12.99%-0.39
15.41%-0.33
---0.23
---0.14
---0.34
---0.39
----
----
----
----
----
Revenue
--21.00M
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-85.86%1.14M
-83.38%742.00K
-79.39%1.50M
18.65%5.90M
94.82%8.08M
--4.46M
--7.28M
--4.97M
--4.15M
----
----
----
Net Profit
----
25.19%-13.53M
58.92%-8.38M
1.82%-16.37M
-4.25%-17.98M
-11.71%-18.09M
-69.96%-20.40M
-101.24%-16.67M
-238.35%-17.25M
-35.14%-16.19M
-0.61%-12.00M
30.63%-8.29M
65.07%-5.10M
21.91%-11.98M
33.24%-11.93M
13.19%-11.94M
78.49%-14.59M
85.02%-15.34M
13.04%-17.87M
-126.73%-13.76M
Net Margin
----
----
----
----
----
----
----
----
-2292.12%-1509.10%
-713.05%-2182.35%
-388.18%-799.67%
---140.50%
---63.09%
---268.41%
---163.81%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
-100.00%0.00%
100.43%49.69%
97.91%40.69%
89.86%34.73%
78.86%29.28%
11.71%24.79%
-8.59%20.56%
-17.75%18.29%
-22.53%16.37%
10.83%22.19%
--22.49%
--22.24%
--21.13%
--20.03%
--0.00%
----
----
----
----
----
Revenue
--21.00M
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-85.86%1.14M
-83.38%742.00K
-79.39%1.50M
18.65%5.90M
94.82%8.08M
--4.46M
--7.28M
--4.97M
--4.15M
----
----
----
Operating profit
140.80%7.16M
50.16%-8.97M
53.72%-9.42M
8.16%-15.73M
7.48%-17.54M
-4.83%-17.99M
-56.98%-20.35M
-85.10%-17.12M
-212.51%-18.96M
-40.41%-17.16M
1.65%-12.96M
26.22%-9.25M
59.48%-6.07M
20.45%-12.22M
26.31%-13.18M
9.10%-12.54M
-36.66%-14.97M
-106.20%-15.37M
-141.94%-17.88M
-127.90%-13.79M
Net Profit
----
25.19%-13.53M
58.92%-8.38M
1.82%-16.37M
-4.25%-17.98M
-11.71%-18.09M
-69.96%-20.40M
-101.24%-16.67M
-238.35%-17.25M
-35.14%-16.19M
-0.61%-12.00M
30.63%-8.29M
65.07%-5.10M
21.91%-11.98M
33.24%-11.93M
13.19%-11.94M
78.49%-14.59M
85.02%-15.34M
13.04%-17.87M
-126.73%-13.76M
Current assets
-71.54%22.89M
-48.41%48.73M
-48.18%58.59M
-45.82%68.17M
-42.04%80.44M
-33.61%94.46M
-18.29%113.07M
-9.64%125.83M
-5.84%138.79M
-9.12%142.28M
-1.31%138.37M
-8.13%139.26M
-4.39%147.40M
7.65%156.56M
-12.96%140.20M
-13.08%151.59M
-17.28%154.16M
71.37%145.44M
--161.07M
--174.40M
Total current liabilities
-48.17%7.86M
230.10%38.52M
138.13%36.15M
41.23%17.60M
32.59%15.17M
-44.99%11.67M
-21.66%15.18M
-13.68%12.46M
-23.75%11.44M
-2.34%21.21M
-19.22%19.38M
-48.06%14.44M
-50.59%15.01M
96.97%21.72M
102.03%23.99M
257.56%27.80M
312.05%30.37M
103.88%11.03M
--11.87M
--7.78M
Total assets
-73.91%24.16M
-45.89%58.02M
-45.33%69.40M
-43.14%79.63M
-39.78%92.57M
-39.62%107.24M
-27.40%126.93M
-20.61%140.04M
-17.02%153.70M
-8.96%177.60M
9.10%174.83M
2.30%176.39M
5.65%185.24M
18.49%195.07M
-10.60%160.25M
-3.34%172.42M
-7.92%175.33M
84.08%164.63M
--179.25M
--178.38M
Total liabilities
-84.61%7.86M
-8.23%45.82M
-16.71%44.59M
-1.27%50.01M
2.85%51.10M
-16.80%49.93M
-15.63%53.54M
-20.78%50.66M
-25.44%49.69M
-18.90%60.01M
67.40%63.46M
54.16%63.94M
46.49%66.64M
192.32%74.00M
43.25%37.91M
357.20%41.48M
413.29%45.49M
256.92%25.31M
--26.46M
--9.07M
Total equity
-60.71%16.29M
-78.71%12.20M
-66.20%24.80M
-66.87%29.61M
-60.14%41.46M
-51.26%57.31M
-34.10%73.39M
-20.51%89.38M
-12.29%104.02M
-2.88%117.59M
-8.96%111.37M
-14.13%112.44M
-8.66%118.60M
-13.10%121.07M
-19.93%122.34M
-22.66%130.95M
-28.48%129.84M
69.19%139.32M
--152.79M
--169.30M
Net operating income
143.72%6.63M
44.07%-10.60M
22.65%-11.02M
-21.62%-15.16M
-6.96%-15.16M
-23.87%-18.95M
-210.84%-14.25M
-72.89%-12.46M
-29.81%-14.18M
-54.55%-15.30M
61.37%-4.58M
50.19%-7.21M
-3504.29%-10.92M
29.05%-9.90M
6.34%-11.87M
-16.55%-14.47M
97.10%-303.00K
-90.43%-13.95M
-110.90%-12.67M
-152.33%-12.42M
Net investment
----
----
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
37.88%-123.00K
98.64%-3.00K
90.66%-17.00K
33.93%-111.00K
61.78%-198.00K
88.69%-221.00K
83.62%-182.00K
-500.00%-168.00K
-90.44%-518.00K
-1815.69%-1.95M
-900.90%-1.11M
-115.38%-28.00K
-2922.22%-272.00K
-78.95%-102.00K
Net financing
----
----
-7.11%2.37M
54666.67%3.27M
103.99%388.00K
-100.00%0.00
-71.93%2.55M
-114.63%-6.00K
-1504.62%-9.72M
-58.33%20.26M
622.37%9.07M
-99.63%41.00K
-79.74%692.00K
30480.50%48.62M
3205.26%1.26M
4113.04%11.08M
-96.90%3.42M
129.55%159.00K
-99.95%38.00K
-184.54%-276.00K

FAQs

What are the current assets of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its current assets were 58.59M, with a year-on-year change of -48.18.

What are the total assets of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its total assets of Werewolf Therapeutics Inc were 69.40M, with a year-on-year change of -45.33.

What are the total liabilities of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its total liabilities of Werewolf Therapeutics Inc were 44.59M, with a year-on-year change of -16.71.

What is the total equity of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its total equity of Werewolf Therapeutics Inc was 24.80M, with a year-on-year change of -66.20.

What is the net operating income of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its net operating income of Werewolf Therapeutics Inc was -60.68M, with a year-on-year change of 17.55.

What is the net financing of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its net financing of Werewolf Therapeutics Inc was 6.03M, with a year-on-year change of -53.91.

What is the Earnings Per Share (EPS) of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.32, with a year-on-year change of 18.78.

What is the net income of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its net income was -60.82M, with a year-on-year change of 13.75.

What is the debt-to-asset ratio of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 40.69, with a year-on-year change of 97.91.

What is the Return on Equity (ROE) of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -123.88, with a year-on-year change of -62.30.

What is the Return on Assets (ROA) of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -61.96, with a year-on-year change of -32.58.

What is the operating profit of Werewolf Therapeutics Inc?

According to Werewolf Therapeutics Inc's FY2025 earnings report, its operating profit was -60.68M, with a year-on-year change of 17.55.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.